TME PHARM.CONF.IPO EO 1- (0N6A) — Working Capital to Net Assets Ratio

TME PHARM.CONF.IPO EO 1- (0N6A) has a Working Capital to Net Assets ratio of 101.1% as of December 2025. Working capital of €-1.60 Million (current assets of €2.12 Million minus current liabilities of €3.72 Million) is measured against net assets of €-1.58 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See how many days can TME PHARM.CONF.IPO EO 1- fund operations to measure how many days the company can operate on defensive assets alone.